Adults aged 75 years or older are increasingly considered for neurosurgical treatment of primary central nervous system tumors, yet the evidence guiding treatment selection remains fragmented. We conducted a scoping review of PubMed/MEDLINE, Ovid Embase, Scopus, and Web of Science from database inception through July 2026....
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change for audiologists — this scoping review addresses neurosurgical decision-making for CNS tumors in the elderly and has no relevance to audiology clinical practice.
As the global population ages, the audiology field may encounter more elderly patients with CNS tumors causing hearing or balance symptoms, but treatment decisions rest entirely with neurosurgeons and oncologists.
- 01Scoping review of neurosurgical intervention for primary CNS (brain and spinal cord) tumors in adults aged 75 or older.
- 02Focus is on how age beyond a simple number influences treatment selection and surgical outcomes.
- 03Review highlights gaps in evidence for operating on the very elderly with brain tumors.
- 04No direct audiology relevance; tangential only if acoustic neuroma or other skull-base tumors are considered.
- 05Findings inform neurosurgical and neuro-oncology guidelines, not audiology protocols.
Chronological age alone is an insufficient criterion for excluding very elderly patients from neurosurgical intervention for CNS tumors.
studypartially supported- PMID
- 42782896
- DOI
- 10.3390/curroncol33090550.
- Journal
- Current Oncology
- Publication type
- review
- Evidence level
- 2a
- Population
- Adults aged 75 or older with primary central nervous system tumors considered for neurosurgical intervention
- Intervention
- Neurosurgical intervention for primary CNS tumors
- Comparator
- Non-surgical management or no intervention
Primary outcomes
Treatment selection criteria beyond chronological age; Surgical outcomes in adults aged 75+